Beijing Tiantan Biological Products Corporation LimitedSSE: 600161

Announcement on Withdrawal of Drug Registration Application by Subsidiary

· Issued by Beijing Tiantan Biological Products Corporation Limited via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

Beijing Tiantan Biological Products Corporation Limited announced the withdrawal of a drug registration application by its subsidiary, Chengdu Rongseng Pharmaceutical Co., Ltd., for a specific recombinant coagulation factor product. The withdrawal was prompted by the need for additional clinical trial data for pediatric patients as per the review comments from the drug regulatory authority. The company plans to resubmit the application after completing the necessary clinical data work.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Withdrawal of Drug Registration Application by Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Beijing Tiantan Biological Products Corporation Limited on 6ix

Earlier from Beijing Tiantan Biological Products

Later from Beijing Tiantan Biological Products

All Beijing Tiantan Biological Products news releases